Dr Reddy's launches generic epilepsy drug in US market

"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Muqig1
via IFTTT